Tocqueville Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-12,000
| Closed | -$333K | – | 773 |
|
|
2019
Q2 | $333K | Sell |
12,000
-8,000
| -40% | -$222K | ﹤0.01% | 663 |
|
|
2019
Q1 | $664K | Hold |
20,000
| – | – | 0.01% | 536 |
|
|
2018
Q4 | $581K | Hold |
20,000
| – | – | 0.01% | 533 |
|
|
2018
Q3 | $920K | Sell |
20,000
-15,053
| -43% | -$692K | 0.01% | 516 |
|
|
2018
Q2 | $1.31M | Sell |
35,053
-8
| -0% | -$299 | 0.02% | 469 |
|
|
2018
Q1 | $1.04M | Hold |
35,061
| – | – | 0.01% | 504 |
|
|
2017
Q4 | $1.2M | Sell |
35,061
-38
| -0.1% | -$1.31K | 0.01% | 490 |
|
|
2017
Q3 | $1.27M | Hold |
35,099
| – | – | 0.01% | 503 |
|
|
2017
Q2 | $907K | Sell |
35,099
-10,000
| -22% | -$258K | 0.01% | 517 |
|
|
2017
Q1 | $866K | Buy |
+45,099
| New | +$866K | 0.01% | 512 |
|